Table 1 Correlation of NKAIN1 expression in cancer tissues with clinicopathologic features in gastric cancer patients.

From: NKAIN1 expression relates to the immune evasion and prognosis of gastric cancer

Characteristic

n

Lower expression (%)

High expression (%)

Pearson χ2

P

Total

305

204 (66.89)

101 (33.11)

  

Gender

   

0.225

0.635

Female

93

64 (68.82)

32 (31.18)

  

Male

212

140 (66.04)

72 (33.96)

  

Age

   

0.283

0.595

<60

109

75 (68.81)

34 (31.19)

  

≥ 60

196

129 (65.82)

67 (34.18)

  

Differentiation

   

5.669

0.059

Well

11

10 (90.91)

1 (9.09)

  

Middle

58

33 (56.90)

25 (43.10)

  

Poor

236

161 (68.22)

75 (31.78)

  

HER2

   

9.636

0.008*

0

212

151 (71.23)

61 (28.77)

  

1+

48

23 (47.92)

25 (52.08)

  

2 + 3+

22

15 (68.18)

7 (31.82)

  

Unknown

     

T

   

9.438

0.024*

Tis-T1

55

43 (78.18)

12 (21.82)

  

T2

44

33 (75.00)

11 (25.00)

  

T3

47

34 (72.34)

13 (27.66)

  

T4

159

94 (59.12)

65 (40.88)

  

N

   

8.632

0.035*

N0

98

75 (76.53)

23 (23.47)

  

N1

46

32 (69.57)

14 (30.43)

  

N2

65

36 (55.38)

29 (44.62)

  

N3

96

61 (63.54)

35 (36.46)

  

M

   

0.067

0.796

M0

298

199 (66.78)

99 (33.22)

  

M1

7

5 (71.43)

2 (28.57)

  

TNM stage

   

8.753

0.013*

0-I

73

57 (78.08)

16 (21.92)

  

II

44

33 (75.00)

11 (25.00)

  

III-IV

188

114 (60.64)

74 (39.36)

  
  1. *P < 0.05.